Asset
TT-301
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01357421 | phase1 | completed | 2011-05-01 | 2011-06-01 | OPKO Health, Inc. | Effects of TT301 on Cytokine Levels Post Endotoxin Challenge |
FDA applications (0)
This company has no applications containing this asset.